Increasing importance of 18F-FDG PET in the diagnosis of neurolymphomatosis

Nuclear Medicine Communications

Volumn 33, Issue 9, 2012, Pages 907-916

  Salm, Liesbeth P ^a   Van Der Hiel, Bernies ^a   Stokkel, Marcel P M ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

18F FDG PET; central and peripheral nervous system; haematological malignancy; neurolymphomatosis

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

B CELL LYMPHOMA; BONE MARROW EXAMINATION; CANCER CHEMOTHERAPY; CANCER REGRESSION; CENTRAL NERVOUS SYSTEM TUMOR; CEREBROSPINAL FLUID ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; LYMPHOMA; MEDLINE; NEUROLYMPHOMATOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; REVIEW; TRIGEMINAL NERVE; TUMOR LOCALIZATION; ANIMAL; MAREK DISEASE; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; SCINTISCANNING;

ANIMALS; FLUORODEOXYGLUCOSE F18; HUMANS; MAREK DISEASE; POSITRON-EMISSION TOMOGRAPHY;

EID: 84864453001     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e3283561881     Document Type: Review

References (53)

1. Baehring JM, Damek D, Martin EC, Betensky RA, Hochberg FH. Neurolymphomatosis. Neuro-Oncology 2003; 5:104-115. (Pubitemid 36416839)
2. Gan HK, Azad A, Cher L, Mitchell PL. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neuro-Oncology 2010; 12:212-215.
3. Rahmani M, Birouk N, Amarti A, Loukili IA, Marnissi F, Belaidi H, et al. T-cell lymphoma revealed by a mononeuritis multiplex: case report and review of literature. Rev Neurol (Paris) 2007; 163:462-470. (Pubitemid 46931924)
4. Levin N, Soffer D, Grissaru S, Aizikovich N, Gomori JM, Siegal T. Primary T-cell CNS lymphoma presenting with leptomeningeal spread and neurolymphomatosis. J Neurooncol 2008; 90:77-83.
5. Kosa SC, Peller PJ, Klein CJ. T-cell neurolymphomatosis involving cauda equina and sciatic nerves. Neurology 2009; 72:98.
6. Grisariu S, Avni B, Batchelor TT, van den Bent MJ, Bokstein F, Schiff D, et al. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood 2010; 115:5005-5011.
7. Kanter P, Zeidman A, Streifler J, Marmelstein V, Even-Sapir E, Metser U, et al. PET-CT imaging of combined brachial and lumbosacral neurolymphomatosis. Eur J Haematol 2005; 74:66-69. (Pubitemid 40143689)
8. Lin M, Kilanowska J, Taper J, Chu J. Neurolymphomatosis-diagnosis and assessment of treatment response by FDG PET-CT. Hematol Oncol 2008; 26:43-45. (Pubitemid 351448911)
9. Van den Bent MJ, de Bruin HG, Bos GM, Brutel de la Rivière G, Sillevis Smitt PA. Negative sural nerve biopsy in neurolymphomatosis. J Neurol 1999; 246:1159-1163. (Pubitemid 30021240)
10. Hutchings M, Specht L. PET/CT in the management of haematological malignancies. Eur J Haematol 2008; 80:369-380. (Pubitemid 351503112)
11. Misdraji J, Ino Y, Louis DN, Rosenberg AE, Chiocca EA, Harris NL. Primary lymphoma of peripheral nerve: report of four cases. Am J Surg Pathol 2000; 24:1257-1265.
12. Baehring J, Cooper D. Neurolymphomatosis. J Neurooncol 2004; 68: 243-244. (Pubitemid 38878258)
13. Dakwar E, Teja S, Alleyne CH Jr. Sciatic neurolymphomatosis. Neurology 2004; 63:1751. (Pubitemid 39507610)
14. Pages M, Marty-Double C, Pages AM. Sensory neuropathy as revealing symptom of neurolymphomatosis: report of a case with a 15-year duration. Eur Neurol 2004; 52:57-58. (Pubitemid 39077817)
15. Bi HY, Na J, Zang GM, Zhang W, Yuan Y. Neurolymphomatosis, a case report. Beijing Da Xue Xue Bao 2005; 37:331.
16. Shibata-Hamaguchi A, Samuraki M, Furui E, Ishida C, Kitagawa S, Nakao S, et al. B-cell neurolymphomatosis confined to the peripheral nervous system. J Neurol Sci 2007; 260:249-252. (Pubitemid 47212198)
17. Tachibana T, Tomita N, Ueda T, Katoh J, Takemura S, Taguchi J, et al. Systemic neurolymphomatosis complicated in diffuse large B-cell lymphoma. Rinsho Ketsueki 2007; 48:1563-1566.
18. Yazawa S, Ohi T, Shiomi K, Takashima N, Kyoraku I, Nakazato M. Brachial plexus neurolymphomatosis: a discrepancy between electrophysiological and radiological findings. Intern Med 2007; 46:533-534. (Pubitemid 46629959)
19. Grisold W, Klimpfinger M, Maehr B, Pont J, Struhal W, Urbanits S, et al. Peripheral nerve involvement in lymphoma: the meninges as the crucial barrier between meningoradicular spread and neurolymphomatosis. J Peripher Nerv Syst 2007; 12:58-60. (Pubitemid 46434539)
20. Chaturvedi A, Singh JP, Rastogi V. MRI diagnosis of neurolymphomatosis of the brachial plexus. Neurol India 2008; 56:485-486.
21. Urban PP, Kaczmarek E, Wellach I, Bruning R, Brullke N, Schulte C, et al. Neurolymphomatosis. Subacute sensorimotor polyneuropathy as a first sign of non-Hodgkin's B cell lymphoma. Nervenarzt 2008; 79: 699-702.
22. Bezier M, Reguiai Z, Delaby P, Laroche L, Said G, Bernard P, et al. Neurolymphomatosis associated with Sezary syndrome. Arch Dermatol 2009; 145:294-296.
23. Hung MH, Gau JP. Relapsed testicular lymphoma presenting with cranial nerve neurolymphomatosis. Neurology 2011; 76:1441.
24. Matsue K, Hayama BY, Iwama K, Koyama T, Fujiwara H, Yamakura M, et al. High frequency of neurolymphomatosis as a relapse disease of intravascular large B-cell lymphoma. Cancer 2011; 117:4512-4521.
25. Koyama T, O'uchi T, Matsue K. Neurolymphomatosis involving the trigeminal nerve and deep peroneal nerve in a patient with relapsed intravascular large B-cell lymphoma. Eur J Haematol 2010; 85:275-276.
26. Salm LP, Van der Hiel B, Stokkel MPM. Neurolymphomatosis diagnosed by F-18 FDG PET-CT. Clin Nucl Med (in press).
27. Trojan A, Jermann M, Taverna C, Hany TF. Fusion PET-CT imaging of neurolymphomatosis. Ann Oncol 2002; 13:802-805. (Pubitemid 34567390)
28. Ghobrial IM, Buadi F, Spinner RJ, Colgan JP, Wolanskyj AP, Dyck PJ, et al. High-dose intravenous methotrexate followed by autologous stem cell transplantation as a potentially effective therapy for neurolymphomatosis. Cancer 2004; 100:2403-2407. (Pubitemid 38657888)
29. Bokstein F, Goor O, Shihman B, Rochkind S, Even-Sapir E, Metser U, et al. Assessment of neurolymphomatosis by brachial plexus biopsy and PET/CT. Report of a case. J Neurooncol 2005; 72:163-167. (Pubitemid 40796467)
30. Kim JH, Jang JH, Koh SB. A case of neurolymphomatosis involving cranial nerves: MRI and fusion PET-CT findings. J Neurooncol 2006; 80:209-210. (Pubitemid 44614805)
31. 18F-FDG PET. Eur J Nucl Med Mol Imaging 2006; 33:975-976. (Pubitemid 44127450)
32. Rosso SM, de Bruin HG, Wu KL, van den Bent MJ. Diagnosis of neurolymphomatosis with FDG PET. Neurology 2006; 67:722-723. (Pubitemid 44273634)
33. Strobel K, Pestalozzi B, Ciernik I, Schaefer NG, Koma AY, Hany TF. Changing PET/CT manifestation of neurolymphomatosis. Eur J Nucl Med Mol Imaging 2006; 33:1244. (Pubitemid 44484482)
34. Hoshikawa Y, Oguri T, Hattori M, Uematsu N, Matsukawa N, Yamawaki T, et al. A case of neurolymphomatosis diagnosed with FDG-PET. Rinsho Shinkeigaku 2007; 47:437-440. (Pubitemid 47266152)
35. Strobel K, Fischer K, Hany TF, Poryazova R, Jung HH. Sciatic nerve neurolymphomatosis-extent and therapy response assessment with PET/CT. Clin Nucl Med 2007; 32:646-648. (Pubitemid 47220608)
36. Czepczyński R, Guzikowska-Ruszkowska I, Sowinski J. Neurolymphomatosis detected by (18)F-FDG PET/CT scan-a case report. Nucl Med Rev Cent East Eur 2008; 11:73-75.
37. Dong Q, Wong KK, Avram AM. Sacral nerve root neurolymphomatosis diagnosed on FDG-PET/CT and magnetic resonance imaging. Clin Nucl Med 2008; 33:30-31.
38. Khong P, Pitham T, Owler B. Isolated neurolymphomatosis of the cauda equina and filum terminale: case report. Spine (Phila Pa 1976) 2008; 33:E807-E811.
39. Shima K, Ishida C, Okino S, Kotani T, Higashi K, Yamada M. A linear lesion along the brachial plexus on FDG-PET in neurolymphomatosis. Intern Med 2008; 47:1159-1160.
40. Umehara F, Hagiwara T, Yoshimura M, Higashi K, Arimura K. Enlarged, multifocal upper limb neuropathy with HTLV-I associated myelopathy in a patient with chronic adult T-cell leukemia. J Neurol Sci 2008; 266:167-170.
41. Chamberlain MC, Fink J. Neurolymphomatosis: a rare metastatic complication of diffuse large B-Cell lymphoma. J Neurooncol 2009; 95:285-288.
42. Durán C, Infante JR, Serrano J, Rayo JI, Garcia L, Dominguez ML, et al. Neurolymphomatosis: diagnosis of extension and assessment of response to treatment with PET-CT. Rev Esp Med Nucl 2009; 28:295-298.
43. Hong RS, Woodson EA, Hansen MR. Neurolymphomatosis mimicking chemotherapy-induced ototoxicity. Otol Neurotol 2009; 30:566-569.
44. Nishio M, Tamaki T, Ochi H, Shibamoto Y. Intraspinal canal neurolymphomatosis detected by FDG-PET/CT. Clin Nucl Med 2009; 34:610-612.
45. Peruzzi P, Ray-Chaudhuri A, Slone WH, Mekhjian HS, Porcu P, Chiocca EA. Reversal of neurological deficit after chemotherapy in BCL-6-positive neurolymphomatosis. Case report. J Neurosurg 2009; 111:247-251.
46. Von Falck C, Rodt T, Joerdens S, Waldeck S, Kiesel H, Knapp WH, et al. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound. Clin Nucl Med 2009; 34:493-495.
47. Miki M, Masaki Y, Nakamura T, Iwao H, Nakajima A, Sakai T, et al. Primary neurolymphomatosis of the cervical nerve root. Rinsho Ketsueki 2010; 51:564-567.
48. Nishizawa M, Yamashita K, Nakamoto Y, Kotani S, Kondo T, Takaori-Kondo A. Neurolymphomatosis as a manifestation of relapsed primary cardiac lymphoma. Int J Hematol 2010; 92:679-680.
49. Santos E, Scolding NJ. Neurolymphomatosis mimicking neurosarcoidosis: a case report. J Med Case Reports 2010; 4:5.
50. Ye BS, Sunwoo IN, Suh BC, Park JP, Shim DS, Kim SM. Diffuse large B-cell lymphoma presenting as piriformis syndrome. Muscle Nerve 2010; 41: 419-422.
51. Suga K,Yasuhiko K, Matsunaga N,Yujiri T, Nakazora T, Ariyoshi K. F-18 FDG PET/CT findings of a case of sacral nerve root neurolymphomatosis that occurred during chemotherapy. Clin Nucl Med 2011; 36:73-76.
52. Talanow R, Shrikanthan S. Value of FDG PET in the evaluation of therapy response in nerve root neurolymphomatosis. Clin Nucl Med 2011; 36: 389-391.
53. Juweid ME, Stroobants S, Hoekstra OS, Mottaghy FM, Dietlein M, Guermazi A, et al. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 2007; 25: 571-578. (Pubitemid 350002965)